Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helal F Hetta

Showing results (11-20 of 213) with videos related to

Pageof 22
Sort By:
Infectious Agents and Cancer|January 8, 2026
Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associationsYasmin N Ramadan, Marah N Alatawi, Abdullah S Albalawi, et al.
Nanomedicine (London, England)|June 6, 2019
Nanomedicine as a future therapeutic approach for Hepatitis C virusNoura H Abd Ellah, Hesham M Tawfeek, James John, et al.
Clinical and Experimental Medicine|September 11, 2024
MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel diseaseYasmin N Ramadan, Ayat M Kamel, Mohammed A Medhat, et al.
Cancer Immunology, Immunotherapy : CII|September 18, 2020
Flow cytometric analysis of circulating endothelial cells and endothelial progenitor cells in pediatric solid tumors: prognostic impact on treatment response and survivalHeba Abdel Razik Sayed, Helal F Hetta, Engy A Shafik, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2020
Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm studyAsmaa M Zahran, Helal F Hetta, Shimaa Mansour, et al.
Scientific Reports|December 17, 2022
Fig latex inhibits the growth of pathogenic bacteria invading human diabetic wounds and accelerates wound closure in diabetic miceMohamed Salah, Gamal Badr, Helal F Hetta, et al.
Journal of Clinical Anesthesia|August 28, 2020
Preoperative Duloxetine to improve acute pain and quality of recovery in patients undergoing modified radical mastectomy: A dose-ranging randomized controlled trialDiab Fuad Hetta, Nourhan Alaa Elgalaly, Helal F Hetta, et al.
Clinical and Experimental Medicine|April 5, 2025
Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systemsAhmed Aljabri, Ghareb M Soliman, Yasmin N Ramadan, et al.
Cancer Management and Research|December 4, 2020
Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing CountriesKhaled Abouelezz, Dipen Khanapara, Gaber El-Saber Batiha, et al.
Journal of Clinical Pathology|August 14, 2013
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)Mohamed Tarek M Shata, Enass A Abdel-Hameed, Helal F Hetta, et al.
Pageof 22

Showing results (11-20 of 213) with videos related to

Sort By:
Pageof 22
Infectious Agents and Cancer|January 8, 2026
Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associationsYasmin N Ramadan, Marah N Alatawi, Abdullah S Albalawi, et al.
Nanomedicine (London, England)|June 6, 2019
Nanomedicine as a future therapeutic approach for Hepatitis C virusNoura H Abd Ellah, Hesham M Tawfeek, James John, et al.
Clinical and Experimental Medicine|September 11, 2024
MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel diseaseYasmin N Ramadan, Ayat M Kamel, Mohammed A Medhat, et al.
Cancer Immunology, Immunotherapy : CII|September 18, 2020
Flow cytometric analysis of circulating endothelial cells and endothelial progenitor cells in pediatric solid tumors: prognostic impact on treatment response and survivalHeba Abdel Razik Sayed, Helal F Hetta, Engy A Shafik, et al.
Cancer Immunology, Immunotherapy : CII|September 12, 2020
Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm studyAsmaa M Zahran, Helal F Hetta, Shimaa Mansour, et al.
Scientific Reports|December 17, 2022
Fig latex inhibits the growth of pathogenic bacteria invading human diabetic wounds and accelerates wound closure in diabetic miceMohamed Salah, Gamal Badr, Helal F Hetta, et al.
Journal of Clinical Anesthesia|August 28, 2020
Preoperative Duloxetine to improve acute pain and quality of recovery in patients undergoing modified radical mastectomy: A dose-ranging randomized controlled trialDiab Fuad Hetta, Nourhan Alaa Elgalaly, Helal F Hetta, et al.
Clinical and Experimental Medicine|April 5, 2025
Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systemsAhmed Aljabri, Ghareb M Soliman, Yasmin N Ramadan, et al.
Cancer Management and Research|December 4, 2020
Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing CountriesKhaled Abouelezz, Dipen Khanapara, Gaber El-Saber Batiha, et al.
Journal of Clinical Pathology|August 14, 2013
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)Mohamed Tarek M Shata, Enass A Abdel-Hameed, Helal F Hetta, et al.
Pageof 22